Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Squassina A, Manchia M, Del Zompo M.

Hum Genomics Proteomics. 2010 Aug 3;2010:159761. doi: 10.4061/2010/159761.

2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
3.

A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.

Yatham LN.

J Affect Disord. 2011 Jan;128 Suppl 1:S21-8. doi: 10.1016/S0165-0327(11)70005-2. Review.

PMID:
21220077
4.

Acute and maintenance treatment with mood stabilizers.

Bowden CL.

Int J Neuropsychopharmacol. 2003 Sep;6(3):269-75. Review.

PMID:
12974993
5.

Pharmacogenomics of bipolar disorder.

Severino G, Squassina A, Costa M, Pisanu C, Calza S, Alda M, Del Zompo M, Manchia M.

Pharmacogenomics. 2013 Apr;14(6):655-74. doi: 10.2217/pgs.13.51. Review.

PMID:
23570469
6.

[Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].

Geoffroy PA, Bellivier F, Henry C.

Encephale. 2014 Sep;40(4):330-7. doi: 10.1016/j.encep.2013.10.007. Epub 2014 Feb 7. Review. French.

7.

Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance.

de Bartolomeis A, Perugi G.

Expert Opin Pharmacother. 2012 Oct;13(14):2027-36. doi: 10.1517/14656566.2012.719876. Epub 2012 Sep 4. Review. Erratum in: Expert Opin Pharmacother. 2012 Nov;13(16):2427.

PMID:
22946707
8.

Pharmacogenomic aspects of bipolar disorder: An update.

Budde M, Degner D, Brockmöller J, Schulze TG.

Eur Neuropsychopharmacol. 2017 Jun;27(6):599-609. doi: 10.1016/j.euroneuro.2017.02.001. Epub 2017 Mar 23.

9.

Classifying mood disorders by age-at-onset instead of polarity.

Benazzi F.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):86-93. doi: 10.1016/j.pnpbp.2008.10.007. Epub 2008 Oct 27.

PMID:
18992784
10.

Treatment-resistant bipolar disorder.

Gitlin M.

Mol Psychiatry. 2006 Mar;11(3):227-40. Review.

PMID:
16432528
11.

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Review.

PMID:
18501566
12.

Can the response to mood stabilizers be predicted in bipolar disorder?

Geoffroy PA, Bellivier F, Leboyer M, Etain B.

Front Biosci (Elite Ed). 2014 Jan 1;6:120-38. Review.

13.

Clinical characteristics and long-term response to mood stabilizers in patients with bipolar disorder and different age at onset.

Dell'Osso B, Buoli M, Riundi R, D'Urso N, Pozzoli S, Bassetti R, Mundo E, Altamura AC.

Neuropsychiatr Dis Treat. 2009;5:399-404.

14.

Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.

Smith LA, Cornelius V, Warnock A, Bell A, Young AH.

Bipolar Disord. 2007 Jun;9(4):394-412. Review.

PMID:
17547586
15.

The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project.

McIntyre RS, Soczynska JK, Cha DS, Woldeyohannes HO, Dale RS, Alsuwaidan MT, Gallaugher LA, Mansur RB, Muzina DJ, Carvalho A, Kennedy SH.

J Affect Disord. 2015 Feb 1;172:259-64. doi: 10.1016/j.jad.2014.09.026. Epub 2014 Oct 12.

PMID:
25451425
16.

Pharmacotherapy of depression and mixed states in bipolar disorder.

Montgomery SA, Schatzberg AF, Guelfi JD, Kasper S, Nemeroff C, Swann A, Zajecka J.

J Affect Disord. 2000 Sep;59 Suppl 1:S39-S56. Review.

PMID:
11121826
17.

The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder.

Calvert NW, Burch SP, Fu AZ, Reeves P, Thompson TR.

J Manag Care Pharm. 2006 May;12(4):322-30.

18.

Bipolar II disorder : epidemiology, diagnosis and management.

Benazzi F.

CNS Drugs. 2007;21(9):727-40. Review.

PMID:
17696573
19.

Mood-stabilizers target the brain arachidonic acid cascade.

Rao JS, Rapoport SI.

Curr Mol Pharmacol. 2009 Jun;2(2):207-14. Review.

20.

[Guidelines for the prescription of mood stabilizers for adolescents: A literature review].

Munch G, Godart N.

Encephale. 2016 Nov 18. pii: S0013-7006(16)30209-3. doi: 10.1016/j.encep.2016.09.005. [Epub ahead of print] French.

PMID:
27871720

Supplemental Content

Support Center